Patients with pulmonary hypertension are at increased risk for postoperative pulmonary complications (PPCs). Herein, we review PPCs in pulmonary hypertension patients undergoing non-cardiac procedures under general anesthesia. The medical records of pulmonary hypertension patients who underwent surgery with general anesthesia between 2010 and 2017 were reviewed for PPCs. In addition we reviewed nursing-documented respiratory depressive episodes in the post-anesthesia care unit to assess the associations between these episodes and 
INTRODUCTION
Pulmonary hypertension (PH) is comprised of a cluster of medical conditions [1, 2] associated with cardiopulmonary dysfunction as well as abnormalities of other organ systems. [3] Patients with PH undergoing surgery have increased risk for postoperative mortality and serious morbidity such as acute right ventricular failure, dysrhythmias, atrial fibrillation, coronary ischemia, respiratory failure and stroke. [4] [5] [6] [7] In general, perioperative outcome reports on patients with PH have focused on cardiovascular complications and have not extensively detailed the incidence or risk factors within that patient population for postoperative pulmonary complications (PPCs). These complications are important because they can result in permanent morbidity and death. Therefore, in this case series we examined the frequency, types and outcomes of PPCs in PH patients undergoing non-cardiothoracic surgery with general anesthesia.
At our institution patients undergoing anesthesia recovery are monitored for episodes of respiratory depression (termed respiratory specific events which are nursing documented episodes of hypoventilation, apnea, oxyhemoglobin desaturation, or patient report of severe pain despite moderate to deep sedation). [8, 9] We have observed that among the general patient surgical population who have a respiratory specific event during anesthesia recovery are at a fivefold increased risk for severe opioid induced respiratory depression on postsurgical wards. [10, 11] Thus, a secondary aim of this study is to also test the hypothesis that respiratory specific events (nursing documented episodes of respiratory depression) during anesthesia recovery are associated with subsequent development of PPCs in surgical patients with PH. To the best of our knowledge, this is the first literature report that focuses exclusively on PPC in the large cohort of patients with PH.
MATERIALS AND METHODS
This study was approved by the Mayo Clinic, Rochester MN, Institutional Review Board.
Consistent with Minnesota Statute 144.295, all patients in this study provided prior authorization for research use of their medical records.
Study population
Adult patients with PH (identified from the Mayo Clinic Pulmonary Hypertension database) who underwent non-cardiac, non-transplant procedures under general anesthesia between February 10, 2010 and December 31, 2017.
Study design
This study is representative of a high-volume surgical practice within a major tertiary academic institution. Patients with PH admitted to the PACU following general anesthesia were identified and their electronic medical records abstracted as previously described. [12] PACU nurses continuously monitored patients for 4 'respiratory specific events': 1) hypoventilation (3 episodes of <8 respirations/minute); 2) apnea (episode lasting 10 seconds); 3) hypoxemia (3 episodes of oxyhemoglobin desaturations [<90%, with or without nasal cannula], as measured by pulse oximetry); and 4) pain-sedation mismatch (defined as Richmond Agitation Sedation Score [13] of −3 to −5 and a numeric pain score >5 [from 0, no pain, to 10, worst pain imaginable]). [8, 9] The PACU records were reviewed to identify episodes of respiratory specific events, and both PACU and postoperative medical records for the presence of PPCs, which were defined as tracheal reintubation, failure to extubate trachea at the end of surgery, de novo application of a noninvasive ventilation (continuous positive airway pressure, CPAP; or bi-level positive airway pressure, BiPAP), administration of naloxone or flumazenil, respiratory failure, pneumonia, pulmonary edema, atelectasis, and pneumothorax.
Data abstraction
Cardiology records were reviewed for PH World Health Organization (WHO) etiological classification and functional limitation classification, [2] objective studies, and therapies of PH for each patient prior to each procedure. Etiologic classifications were Group 1 (pulmonary arterial hypertension due to etiologies such as familial, HIV, toxic, related to congenital heart disease, drugs and medications, etc.), Group 2 (PH due to left heart diseases, left heart failure, severe mitral valve, aortic valve disease, etc.), Group 3 (PH due to lung diseases or hypoxia, or both), Group 4 (chronic thromboembolic PH), and Group 5 (PH due to unclear or multifactorial mechanisms, connective tissue disease, sarcoidosis, mediastinal tumors, thyroid disease etc.). [2, 14] Patients in this cohort with Group 2 or Group 3 PH were felt by cardiologists with expertise in the management of PH to have mixed etiology PH with a component of pulmonary arteriopathy and hence were treated with pulmonary targeted therapy. WHO functional classifications was used to describe the classes (severity) of disease: [2, 15] class I, no physical activity limitation; class II, slight limitation but comfortable at rest; class III, marked limitation of physical activity but comfortable at rest; less than ordinary physical activity causes dyspnea, fatigue, chest pain, or near syncope; and class IV, patients are unable to carry out any physical activity without symptoms. Severity of PH was also assessed from clinical testing and we report preoperative results of the 6-minute walk test which was dichotomized (≥330 vs. <330 meters). [16, 17] N-terminal fragment of the prohormone brain natriuretic peptide (NT-proBNP) is a biochemical marker used in risk stratification of patients with congestive heart failure [18] and for the purpose of this study was dichotomized using a cut-point of <300 pg/mL which has been shown to have a 99% negative predictive value for excluding acute congestive heart failure. [19] Data from echocardiogram, heart catheterization, and pulmonary function tests were also abstracted. In addition, records were abstracted for pertinent comorbid disorders (e.g., treatment for hypertension, asthma, etc.) as well as the regular use of sedating psychometric medications (opioids, benzodiazepines, and gabapentinoids) which have been previously assessed as contributing to PPCs. [20, 21] Periprocedural records were reviewed for surgical duration, anesthetic agents, vasoactive pharmacologic treatments, fluids administered and blood transfusions, the occurrence of respiratory depression in the PACU, and the development of PPCs. Opioid analgesics were converted to intravenous morphine equivalents using standard formulas. [22, 23] The clinical course of patients who had one or more PPCs were reviewed and summarized.
Statistical analyses
Patient and procedural characteristics are summarized using count and percentage for nominal or dichotomous variables and mean  standard deviation [SD] The presentation and clinical course for patients who had a PPC in the PACU is summarized in Table 3 . Four of these PACU PPCs were primarily related to hypoventilation, hypoxemia, and volume overload. These were resolved with tracheal reintubation (n=1), CPAP (n=2), and furosemide treatment and supplemental oxygen (n=1). The fifth patient had developed intraoperative cardiac arrest was taken intubated to the PACU, where she remained unarousable and subsequently was admitted to the intensive care unit.
A subset analysis was performed which excluded the 5 patients who experienced PPC in the The clinical courses of patients who had one or more PPCs after discharge from the PACU are summarized in Table 4 . These PPCs were acute hypoxemia, hypercarbia, respiratory distress and shortness of breath attributed to pneumonia (n=3), pneumothorax (n=1), pulmonary edema (n=1), acute respiratory failure due to mechanical causes (n=1), and respiratory failure due to unknown causes (n=9). Two of these 15 patients required tracheal reintubation. One was a 56-year-old woman who developed apnea and hypotension on the second postoperative day and required mechanical ventilation for 4 days. The second was a 74-year-old woman who developed abdominal wound dehiscence and sepsis on the fourth postoperative day, resulting in respiratory failure; she was re-intubated and re-operated.
The patients with PPCs in our case series achieved complete resolution of respiratory complications, and all were successfully discharged from the hospital (Tables 3 and 4 ) and alive at 30 days. The hospital length of stay was greater among patients with PPCs (median 8 [3, 13] days) compared to those without PPCs (median 2 [1, 6] days), P<0.001.
DISCUSSION
Our most significant finding is a PPC rate of 10.2 per 100 cases in patients with PH. This rate is substantially lower than the rate we found in an earlier study (time-frame between 1991-2003) of a similar PH patient population. In that earlier study, we found a PPC rate of 28 per 100 cases in patients with PH. [24] The reduction in PPC rate between these two time-frames could be due to enhanced perioperative care and improvements in medical management. One important practice difference between the PPC rate in the present and our earlier study is the universal use of new therapies for PH in the contemporary cohort. Many of these treatments were either unavailable or were not widely used during the time frame of earlier study. [24] It has been shown that pulmonary vasodilators specifically the use of prostacyclin receptor agonists improve WHO functional class with a reduction in complication and mortality rates in patients with pulmonary arterial hypertension. [25, 26] Another more contemporary study by Kaw[27] covered the timeframe between 2002-2006 and reported 7.3 PPCs per 100 cases, which is similar to that found in the present study.
Respiratory complications after surgery may be especially frequent in high-acuity PH patients.
For example, Lai [28] reported 21% of delayed tracheal extubation in PH patients undergoing non-cardiac surgery. Collisson [29] described 6 patients who underwent orthotopic liver transplantation for severe hepato-pulmonary syndrome, 3 developed a PPC, including lobe collapse, plural effusion, and pneumonia, and 5 out of 6 required oxygen support at the time of hospital discharge. The other high-risk surgery is cardiothoracic procedures, and PH patients undergoing these surgeries are at heightening risk for prolonged postoperative ventilatory support. [30] In this study, patients who experienced episode of respiratory depression, as assessed from the respiratory specific events in the PACU, had higher rates of PPCs after transfer to general surgical wards. This is consistent with earlier observations that respiratory depression in the PACU is a marker for increased risk for postoperative respiratory complications. [9, 31] This finding suggests that PH patients who experience any presentation of respiratory depression (respiratory specific events) in the PACU may benefit from higher levels of postoperative care
and monitoring. The presentation and clinical course of PPCs in our patients were serious and, in some, life-threatening, but with intense treatment all our patients achieved resolution and all were discharged home.
Fifteen of 20 PPCs occurred within the first 24-postoperative hours which is consistent the temporal patterns of respiratory failure in the general surgical population. [32] We did not observe a significant association between PH severity and PPCs, an unexpected observation because two large series of surgical patients found link between PH severity and adverse outcomes. [24, 27] By limiting our outcome of interest to PPC only, our study may lack the power to detect such associations (see Table 1 , WHO Functional Type class ≥III was present in 60% vs. 40.1 % patients with PPC vs. not, respectively; P=0.099). We observed an increased PPC rate among current or former smokers, consistent with our previous study. [24] Also PPC rates were higher among patients on chronic benzodiazepine therapy. We previously found that chronic use of sedating medications in the general surgical population was associated with postoperative opioid induced respiratory depression. [10] Pulmonary complications were also higher among patients undergoing emergent surgery.
Limitations of the study. This study has the inherent limitations of a retrospective study design, specifically details regarding practice management goals (eg, goal blood pressure, oxygen level, fluid goals) are not able to be deduced. Even though the rate of PPCs was high, the cohort size was limited and these patients had considerable variation in functional class and underwent a wide variety of surgical procedures. Therefore, we were unable to perform more sophisticated analyses of association between risk for PPCs and different patient and procedural variables. In addition, this study was conducted in a major tertiary center with considerable experience with high acuity patients; thus, our observations may not be generalizable to other medical practices.
In conclusion, the rate of PPC in population of contemporary ( hours. This finding, along with the fact that patients who were diagnosed with a respiratory specific event in the recovery room were more likely to experience PPCs following discharge from the PACU, suggest that respiratory status of PH patients should be closely monitored in immediate postoperative period.
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